dc.contributor.author |
Pantea, V. |
|
dc.contributor.author |
Cebotarescu, V. |
|
dc.contributor.author |
Smesnoi, V. |
|
dc.date.accessioned |
2020-03-30T22:15:03Z |
|
dc.date.available |
2020-03-30T22:15:03Z |
|
dc.date.issued |
2010 |
|
dc.identifier.citation |
PANTEA, V., CEBOTARESCU, V., SMESNOI, V. TThe treatment with cytomix of patients with chronic viral hepatitis B, C and mixed B and C. In: Curierul Medical. 2010, nr. 6(318), pp. 58-61. ISSN 1875-0666. |
en_US |
dc.identifier.issn |
1875-0666 |
|
dc.identifier.uri |
http://moldmedjournal.md/wp-content/uploads/2016/09/28.pdf |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/8344 |
|
dc.description |
Department of Contagious Diseases, Postgraduate Study Faculty, Nicolae Testemitanu State Medical and Pharmaceutical University, Clinical Hospital of Contagious Diseases “Toma Ciorba,” Chisinau, Republic of Moldova |
en_US |
dc.description.abstract |
The treatment with cytomix of 20 patients with chronic viral hepatitis B, C, and mixed B+C, for the duration of three months was favored.
The improvement of clinical symptoms in patients with HVBC, HVC, and HVBC+HVCC. The decrease and normalization of liver and spleen
sizes, and moderate decrease of cytolysis indices values (ALAT, ASAT). Seroconversion in the AgHBs and anti-Hbs system with the formation
of anti-HBs (protective antibodies) in one of nine patients with the diagnosis HVBC. The improvement of immune status indices, which was
more marked in patients with HVBC and HVBC+HVCC; there were no noted clinical, biochemical or immunological improvements in the
patients of the control group. |
en_US |
dc.description.abstract |
Лечение цитомиксом проводилось у 20 больных вирусными гепатитами В и С и микст гепатитами В+С в течении 3-х месяцев.
Лечение привело к исчезновению клинической симптоматики, нормализации размеров печени и селезенки и снижению активности
АЛАТ и АСАТ. Произошла сероконверсия в системе НBsAg и анти-HBs с образованием анти-HBs у одного больного из 9 с хроническим
вирусным гепатитом В. Улучшение иммунологического статуса было более выражено у больных с хроническим вирусным гепатитом
В и микст гепатитом В+С, чего не наблюдалось у пациентов контрольной группы. |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” |
en_US |
dc.relation.ispartof |
Curierul Medical |
|
dc.subject |
chronic |
en_US |
dc.subject |
viral |
en_US |
dc.subject |
hepatitis B |
en_US |
dc.subject |
C |
en_US |
dc.subject |
Cytomix |
en_US |
dc.subject.mesh |
Hepatitis B, Chronic--drug therapy |
en_US |
dc.subject.mesh |
Hepatitis С, Chronic--drug therapy |
en_US |
dc.subject.mesh |
Citomix--therapeutic use |
en_US |
dc.title |
The treatment with cytomix of patients with chronic viral hepatitis B, C and mixed B and C |
en_US |
dc.title.alternative |
Лечение цитомиксом больных хроническим вирусным гепатитом В и С и микст гепатитом В+С |
en_US |
dc.type |
Article |
en_US |